JPWO2020256060A1 - - Google Patents

Info

Publication number: JPWO2020256060A1
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2021526872A

Other languages

Other versions

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-06-19

Filing date

2020-06-18

Publication date

2020-12-24

2020-06-18 Application filed filed Critical

2020-12-24 Publication of JPWO2020256060A1 publication Critical patent/JPWO2020256060A1/ja

2024-05-09 Application granted granted Critical

2024-05-09 Publication of JP7479709B2 publication Critical patent/JP7479709B2/en

Status Active legal-status Critical Current

2040-06-18 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

JP2021526872A 2019-06-19 2020-06-18 Anti-infective agent that reduces the bone formation inhibitory effect of vancomycin Active JP7479709B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2019113407		2019-06-19
JP2019113407		2019-06-19
PCT/JP2020/023936 WO2020256060A1 (en)	2019-06-19	2020-06-18	Anti-infective agent with reduced effect of vancomycin on bone formation inhibition

Publications (2)

Publication Number	Publication Date
JPWO2020256060A1 true JPWO2020256060A1 (en)	2020-12-24
JP7479709B2 JP7479709B2 (en)	2024-05-09

Family

ID=74040843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2021526872A Active JP7479709B2 (en)	2019-06-19	2020-06-18	Anti-infective agent that reduces the bone formation inhibitory effect of vancomycin

Country Status (2)

Country	Link
JP (1)	JP7479709B2 (en)
WO (1)	WO2020256060A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009544411A (en) *	2006-07-26	2009-12-17	ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア	Bone formation enhancing composition
WO2010087517A1 (en) *	2009-01-30	2010-08-05	帝人ファーマ株式会社	Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism

2020
- 2020-06-18 WO PCT/JP2020/023936 patent/WO2020256060A1/en active Application Filing
- 2020-06-18 JP JP2021526872A patent/JP7479709B2/en active Active

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009544411A (en) *	2006-07-26	2009-12-17	ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア	Bone formation enhancing composition
WO2010087517A1 (en) *	2009-01-30	2010-08-05	帝人ファーマ株式会社	Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EDER C ET AL.: "Does intrawound application of vancomycin influence bone healing in spine surgery?", EUROPEAN SPINE JOURNAL, vol. 25, no. 4, JPN6020026196, 2016, pages 1021 - 1028, ISSN: 0005211302 *
SHEKHAR C: "An Innovative Technique in Local Antibiotic Delivery Method in Open Infected Wounds of the Musculosk", THE INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, vol. 18(2), JPN6020026193, 8 May 2019 (2019-05-08), pages 153 - 160, ISSN: 0005211301 *

Also Published As

Publication number	Publication date
WO2020256060A1 (en)	2020-12-24
JP7479709B2 (en)	2024-05-09

Publication	Publication Date	Title
BR112021017339A2 (en)	2021-11-16
BR112021018450A2 (en)	2021-11-23
BR112021017939A2 (en)	2021-11-16
BR112021017738A2 (en)	2021-11-16
BR112021017892A2 (en)	2021-12-07
BR112021017782A2 (en)	2021-11-23
BR112021017637A2 (en)	2021-11-09
BR112021018168A2 (en)	2021-11-16
BR112021017728A2 (en)	2021-11-16
BR112021018452A2 (en)	2021-12-21
BR112021017234A2 (en)	2021-11-09
BR112021017355A2 (en)	2021-11-16
BR112021017703A2 (en)	2021-11-16
BR112021018102A2 (en)	2021-11-23
BR112021017173A2 (en)	2021-11-09
BR112021018584A2 (en)	2021-11-23
BR112021017083A2 (en)	2021-11-09
BR112021012348A2 (en)	2021-11-16
BR112021018250A2 (en)	2021-11-23
BR112021018084A2 (en)	2021-12-21
BR112021018093A2 (en)	2021-11-23
BR112021018484A2 (en)	2021-11-23
BR112021017732A2 (en)	2021-11-16
BR112021017949A2 (en)	2021-11-23
BR112021017983A2 (en)	2021-11-16

Legal Events

Date	Code	Title	Description
2023-01-13	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230113
2023-12-05	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231205
2024-01-26	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240126
2024-03-26	TRDD	Decision of grant or rejection written
2024-04-02	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240402
2024-04-19	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240417
2024-05-08	R150	Certificate of patent or registration of utility model	Ref document number: 7479709 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150